QuiaPEG

Newsroom

Se nyheter från:
Page:
123456
Apr 05, 2019

QuiaPEG Pharmaceuticals Holding AB (publ) receives so-called "Notice of Allowance" on granting of a patent in the United States

Mar 28, 2019

QuiaPEG Pharmaceuticals Holding AB (publ) receives "Notice of Acceptance" on granting of a patent in Australia.

Mar 12, 2019

QuiaPEG Pharmaceuticals Holding AB (publ.) announces that a patent application within the fast-growing area of antibody drug conjugates* (ADC) has been submitted to the American patent office (USPTO). Granting of the application will mean that QuiaPEG will have patent protection up to and including 2013.

Feb 01, 2019

QuiaPEG Pharmaceuticals Holding AB (publ), "QuiaPEG", today announces that the company has decided on a directed new issue of shares and warrants to three investors.

QuiaPEG Pharmaceuticals Holding AB ("the Company"), listed on Spotlight, today announces that the Company's Board of Directors made the decision on February 1, 2019, with the support of authorization from the Annual General Meeting on June 18, 2018, to carry out a directed new issue of 2,058,824 shares and 2,058,824 warrants.

Page:
123456
Contact
QuiaPEG Pharmaceuticals Holding AB

Virdings Allé 32 B
754 54 Uppsala
Sweden
+46 (0) 70 693 12 53
info@quiapeg.com

User terms & privacy policy
Send a message